NCT00285194View on ClinicalTrials.gov

hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

April 30, 2000

Primary Completion Date

January 31, 2004

Study Completion Date

January 31, 2004

Conditions
Type 1 DiabetesHypoglycemia
Interventions
DRUG

Allogeneic Islets of Langerhans

DRUG

hOKT3γ1 (Ala-Ala)

Trial Locations (1)

55455

Universtiy of Minnesota, Minneapolis

Sponsors
All Listed Sponsors
collaborator

Juvenile Diabetes Research Foundation

OTHER

lead

University of Minnesota

OTHER